Cite
HARVARD Citation
Bhatty, M. et al. (2019). Phase 1 study of the combination of vemurafenib, carboplatin, and paclitaxel in patients with BRAF‐mutated melanoma and other advanced malignancies. Cancer. 125 (3), pp. 463-472. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Bhatty, M. et al. (2019). Phase 1 study of the combination of vemurafenib, carboplatin, and paclitaxel in patients with BRAF‐mutated melanoma and other advanced malignancies. Cancer. 125 (3), pp. 463-472. [Online].